Obalon Therapeutics, Inc. (OBLN) CEO Bill Plovanic on Q4 2019 Results - Earnings Call Transcript

Obalon Therapeutics, Inc. (OBLN) Q4 2019 Results Earnings Conference Call February 27, 2020 8:30 AM ET

Company Participants

Bill Plovanic - President and Chief Executive Officer
Bob MacDonald - Chief Retail Officer
Nooshin Hussainy - Chief Financial Officer

Conference Call Participants

Kyle Rose - Canaccord
Ryan Zimmerman - BTIG
Ben Haynor - Alliance Global Partners

Operator

Good day, ladies and gentlemen. And welcome to the Obalon Therapeutics Fourth Quarter and Year-end 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session and instructions will follow at that time. As a reminder, this call is being recorded.

I would now like to turn the conference over to Bill Plovanic, President and Chief Executive Officer for Obalon. Mr. Plovanic, you may begin, sir.

Bill Plovanic

Thank you, operator. Good morning. And welcome to Obalon Therapeutics fourth quarter and year-end 2019 financial results conference call. With me on today's call are Bob MacDonald, Chief Retail Officer, who's responsible for driving future site expansion for the Obalon Center for Weight Loss retail treatment center model. A function that's similar to a role he played with Sono Bello, the largest aesthetic surgery chain in the United States. Also on today's call is Nooshin Hussainy, our Chief Financial Officer.

This morning, the company issued a press release detailing our financial results for the three months ended September 30, 2019. This release can be accessed through the Investor Relations section of the Obalon Web site at www.obalon.com, and you can also access the webcast of this call from there.

Before we get started, I'd like to remind everyone that any statements made on today's conference call that express belief, expectation, projection, forecast, anticipation or intent regarding future events and the company's future performance may be considered forward-looking